Comparable stake leader
INTEGRATED CORE STRATEGIES (US) LLC
SEC ownership of BioXcel Therapeutics, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001720893.
Disclosed value leader
Rashmi Agarwal
Comparable rows
43/50
Latest evidence
31 Mar 2026
- Public ticker
- BTAI on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
INTEGRATED CORE STRATEGIES (US) LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
43 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
INTEGRATED CORE STRATEGIES (US) LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
31 Mar 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001720893
- Issuer location
- New Haven, CT
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of BioXcel Therapeutics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
INTEGRATED CORE STRATEGIE...
Disclosed value leader
Rashmi Agarwal
Comparable rows
43/50
Latest evidence
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 8.4%
7 rows are not safely comparable across share classes.
13D/G row: INTEGRATED CORE STRATEGIES (US) LLC
Showing 1-8 of 50 holder rows.
Quick read
INTEGRATED CORE STRATEGIES (US) LLC leads the comparable SEC ownership view at 8.4%.
43 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens INTEGRATED CORE STRATEGIES (US) LLC's linked filing trail.
Comparable ownership
Top 5
INTEGRATED CORE STRATEGIES (US) LLC
8.4%
ARMISTICE CAPITAL, LLC
7%
Oaktree Capital Group Holdings GP...
2.7%
Qatar Investment Authority
0.6%
MILLENNIUM MANAGEMENT LLC
8.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
Millennium Management LLC
|
8.4%
|
$3,762,144
1,835,192 shares
|
+$1,654,635 | 31 Dec 2025 |
| ARMISTICE CAPITAL, LLC |
13F
13D/G
Company
|
7%
from 13D/G
|
$2,559,502
1,910,076 shares
|
— | 31 Mar 2026 |
| Oaktree Capital Group Holdings GP, LLC |
13D/G
Oaktree Capital Holdings, LLC
|
2.7%
|
$28,939
170,230 shares
|
-$434,154 | 31 Mar 2025 |
| Qatar Investment Authority |
13D/G
|
0.6%
|
$26,531
156,066 shares
|
-$436,562 | 31 Dec 2025 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
8.9%
|
$2,595,258
1,936,760 shares
|
— | 31 Mar 2026 |
| OAKTREE CAPITAL MANAGEMENT LP |
13F
Company
|
1.1%
|
$323,193
241,188 shares
|
— | 31 Mar 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.1%
|
$308,725
230,168 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
0.95%
|
$277,834
207,339 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$43,073.
Buys
$0
Insiders: 0
Sells
$43,073
Insiders: 4
Net
-$43,073
Shares: -39,669
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 39,669
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 39,669 | $0 | $43,073 | -$43,073 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 33 reporting-owner rows connected to BioXcel Therapeutics, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
33
Largest Forms 3/4/5 holder
Vipin Agarwal
Net 12M change
-$43,073
Latest report
15 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Vipin Agarwal | 10%+ Owner | $187,267,747 | Mixed | 03 Apr 2023 | ||
| Rashmi Agarwal | 10%+ Owner | $187,267,747 | Mixed | 03 Apr 2023 | ||
| Tarun K. Gupta | 10%+ Owner | $187,168,169 | Mixed | 03 Apr 2023 | ||
| Indu R. Gupta | 10%+ Owner | $187,168,169 | Mixed | 03 Apr 2023 | ||
| Suganthi Balasubramanian | 10%+ Owner | $187,110,248 | Mixed | 03 Apr 2023 | ||
| Anita Jain | 10%+ Owner | $187,100,398 | Mixed | 03 Apr 2023 | ||
| Diwakar Jain | 10%+ Owner | $187,100,398 | Mixed | 03 Apr 2023 | ||
| Michael James Aiello | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Anesha Agarwal | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Pardeep Kumar Sood | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Marshal D. Gibson | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Krishnan Nandabalan | Director, 10%+ Owner | $187,088,358 | Mixed | 06 Apr 2023 | ||
| BioXcel Holdings, Inc. | 10%+ Owner | $187,088,358 | Mixed | 25 Jun 2021 | ||
| BioXcel LLC | 10%+ Owner | $187,088,358 | Mixed | 25 Jun 2021 | ||
| Akrati Agarwal | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Bina Jatin Patel | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Jatin Markand Patel | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Krunal Dilip Patel | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Alka Sood | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Ph.D. Vimal Mehta | CEO and President, Director | $738,228 | -$21,108 | -2.8% | Mixed | 15 Jun 2026 |
Recent insider transactions for BioXcel Therapeutics, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Javier Rodriguez | BTAI | Common Stock | Options Exercise | 0.13% | 35 | 26,838 | 15 Jun 2026 | Direct | ||
| Javier Rodriguez | BTAI | Restricted Stock Units | Options Exercise | -14.2% | -35 | 212 | 15 Jun 2026 | Direct | ||
| Richard I. Steinhart | BTAI | Common Stock | Options Exercise | 0.13% | 35 | 26,335 | 15 Jun 2026 | Direct | ||
| Richard I. Steinhart | BTAI | Restricted Stock Units | Options Exercise | -14.2% | -35 | 212 | 15 Jun 2026 | Direct | ||
| Ph.D Frank Yocca | BTAI | Common Stock | Options Exercise | 0.13% | 35 | 26,210 | 15 Jun 2026 | Direct | ||
| Ph.D Frank Yocca | BTAI | Restricted Stock Units | Options Exercise | -14.2% | -35 | 212 | 15 Jun 2026 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Common Stock | Options Exercise | 0.31% | 219 | 69,817 | 15 Jun 2026 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Restricted Stock Units | Options Exercise | -14.3% | -219 | 1,313 | 15 Jun 2026 | Direct | ||
| Ph.D Frank Yocca | BTAI | Common Stock | Sale | -20.7% | $7,427 | $1.08 | -6,845 | 26,175 | 20 May 2026 | Direct |
| Javier Rodriguez | BTAI | Common Stock | Sale | -19.7% | $7,111 | $1.08 | -6,560 | 26,803 | 20 May 2026 | Direct |
| Richard I. Steinhart | BTAI | Common Stock | Sale | -20.6% | $7,427 | $1.08 | -6,845 | 26,300 | 20 May 2026 | Direct |
| Ph.D. Vimal Mehta | BTAI | Common Stock | Sale | -21.8% | $21,108 | $1.09 | -19,419 | 69,598 | 20 May 2026 | Direct |
| Ph.D Frank Yocca | BTAI | Common Stock | Options Exercise | 112.8% | 17,500 | 33,020 | 04 May 2026 | Direct | ||
| Ph.D Frank Yocca | BTAI | Restricted Stock Units | Options Exercise | -25% | -17,500 | 52,500 | 04 May 2026 | Direct | ||
| Javier Rodriguez | BTAI | Common Stock | Options Exercise | 110.3% | 17,500 | 33,363 | 04 May 2026 | Direct | ||
| Javier Rodriguez | BTAI | Restricted Stock Units | Options Exercise | -25% | -17,500 | 52,500 | 04 May 2026 | Direct | ||
| Richard I. Steinhart | BTAI | Common Stock | Options Exercise | 111.9% | 17,500 | 33,145 | 04 May 2026 | Direct | ||
| Richard I. Steinhart | BTAI | Restricted Stock Units | Options Exercise | -25% | -17,500 | 52,500 | 04 May 2026 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Common Stock | Options Exercise | 126.7% | 49,758 | 89,017 | 04 May 2026 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Restricted Stock Units | Options Exercise | -25% | -49,758 | 149,274 | 04 May 2026 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Common Stock | Options Exercise | 84.7% | 18,000 | 39,259 | 01 May 2026 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Restricted Stock Units | Options Exercise | -100% | -18,000 | 0 | 01 May 2026 | Direct | ||
| Richard I. Steinhart | BTAI | Common Stock | Options Exercise | 135.4% | 9,000 | 15,645 | 01 May 2026 | Direct | ||
| Richard I. Steinhart | BTAI | Restricted Stock Units | Options Exercise | -100% | -9,000 | 0 | 01 May 2026 | Direct | ||
| Ph.D Frank Yocca | BTAI | Common Stock | Options Exercise | 138% | 9,000 | 15,520 | 01 May 2026 | Direct | ||
| Ph.D Frank Yocca | BTAI | Restricted Stock Units | Options Exercise | -100% | -9,000 | 0 | 01 May 2026 | Direct | ||
| Javier Rodriguez | BTAI | Common Stock | Options Exercise | 131.1% | 9,000 | 15,863 | 01 May 2026 | Direct | ||
| Javier Rodriguez | BTAI | Restricted Stock Units | Options Exercise | -100% | -9,000 | 0 | 01 May 2026 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Common Stock | Options Exercise | 1.04% | 219 | 21,259 | 15 Mar 2026 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Restricted Stock Units | Options Exercise | -12.5% | -219 | 1,532 | 15 Mar 2026 | Direct | ||
| Richard I. Steinhart | BTAI | Common Stock | Options Exercise | 0.53% | 35 | 6,645 | 15 Mar 2026 | Direct | ||
| Richard I. Steinhart | BTAI | Restricted Stock Units | Options Exercise | -12.4% | -35 | 247 | 15 Mar 2026 | Direct | ||
| Javier Rodriguez | BTAI | Common Stock | Options Exercise | 0.51% | 35 | 6,863 | 15 Mar 2026 | Direct | ||
| Javier Rodriguez | BTAI | Restricted Stock Units | Options Exercise | -12.4% | -35 | 247 | 15 Mar 2026 | Direct | ||
| Ph.D Frank Yocca | BTAI | Common Stock | Options Exercise | 0.54% | 35 | 6,520 | 15 Mar 2026 | Direct | ||
| Ph.D Frank Yocca | BTAI | Restricted Stock Units | Options Exercise | -12.4% | -35 | 247 | 15 Mar 2026 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Common Stock | Options Exercise | 0.79% | 164 | 21,040 | 14 Mar 2026 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Restricted Stock Units | Options Exercise | -25.2% | -164 | 488 | 14 Mar 2026 | Direct | ||
| Richard I. Steinhart | BTAI | Common Stock | Options Exercise | 0.5% | 33 | 6,610 | 14 Mar 2026 | Direct | ||
| Richard I. Steinhart | BTAI | Restricted Stock Units | Options Exercise | -25.4% | -33 | 97 | 14 Mar 2026 | Direct | ||
| Javier Rodriguez | BTAI | Common Stock | Options Exercise | 0.49% | 33 | 6,828 | 14 Mar 2026 | Direct | ||
| Javier Rodriguez | BTAI | Restricted Stock Units | Options Exercise | -25.4% | -33 | 97 | 14 Mar 2026 | Direct | ||
| Ph.D Frank Yocca | BTAI | Common Stock | Options Exercise | 0.51% | 33 | 6,485 | 14 Mar 2026 | Direct | ||
| Ph.D Frank Yocca | BTAI | Restricted Stock Units | Options Exercise | -25.4% | -33 | 97 | 14 Mar 2026 | Direct | ||
| Sandeep Laumas | BTAI | Stock Option (Right to Buy) | Award | 17,000 | 17,000 | 09 Jan 2026 | Direct | |||
| Rajiv Patni | BTAI | Stock Option (Right to Buy) | Award | 17,000 | 17,000 | 09 Jan 2026 | Direct | |||
| Peter Mueller | BTAI | Stock Option (Right to Buy) | Award | 17,000 | 17,000 | 09 Jan 2026 | Direct | |||
| Michal Votruba | BTAI | Stock Option (Right to Buy) | Award | 17,000 | 17,000 | 09 Jan 2026 | Direct | |||
| Michael Patrick Miller | BTAI | Stock Option (Right to Buy) | Award | 17,000 | 17,000 | 09 Jan 2026 | Direct | |||
| June Bray | BTAI | Stock Option (Right to Buy) | Award | 17,000 | 17,000 | 09 Jan 2026 | Direct |
* marks a reported price that did not pass the local price check.